PT2441767E - Salinosporamidas e seus métodos de utilização - Google Patents
Salinosporamidas e seus métodos de utilização Download PDFInfo
- Publication number
- PT2441767E PT2441767E PT111637377T PT11163737T PT2441767E PT 2441767 E PT2441767 E PT 2441767E PT 111637377 T PT111637377 T PT 111637377T PT 11163737 T PT11163737 T PT 11163737T PT 2441767 E PT2441767 E PT 2441767E
- Authority
- PT
- Portugal
- Prior art keywords
- salinosporamides
- methods
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/407—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with other heterocyclic ring systems, e.g. ketorolac, physostigmine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/397—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having four-membered rings, e.g. azetidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
- A61K31/424—Oxazoles condensed with heterocyclic ring systems, e.g. clavulanic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/429—Thiazoles condensed with heterocyclic ring systems
- A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
- C07D491/044—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
- C12P17/18—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms containing at least two hetero rings condensed among themselves or condensed with a common carbocyclic ring system, e.g. rifamycin
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
- C12P17/18—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms containing at least two hetero rings condensed among themselves or condensed with a common carbocyclic ring system, e.g. rifamycin
- C12P17/188—Heterocyclic compound containing in the condensed system at least one hetero ring having nitrogen atoms and oxygen atoms as the only ring heteroatoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Genetics & Genomics (AREA)
- General Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biochemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biotechnology (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines Containing Plant Substances (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US10/600,854 US7179834B2 (en) | 2002-06-24 | 2003-06-20 | Salinosporamides and methods for use thereof |
US10/838,157 US7176232B2 (en) | 2002-06-24 | 2004-04-30 | Salinosporamides and methods for use thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
PT2441767E true PT2441767E (pt) | 2015-10-09 |
Family
ID=46713688
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PT111637377T PT2441767E (pt) | 2003-06-20 | 2004-06-18 | Salinosporamidas e seus métodos de utilização |
Country Status (8)
Country | Link |
---|---|
KR (1) | KR101315595B1 (ko) |
CY (1) | CY1116724T1 (ko) |
DK (1) | DK2441767T3 (ko) |
ES (1) | ES2546415T3 (ko) |
IL (1) | IL240236B (ko) |
MX (1) | MX361003B (ko) |
PT (1) | PT2441767E (ko) |
SI (1) | SI2441767T1 (ko) |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU4322802A (en) | 2000-11-16 | 2002-06-24 | Univ California | Marine actinomycete taxon for drug and fermentation product dicovery |
-
2004
- 2004-06-18 KR KR1020127016459A patent/KR101315595B1/ko active IP Right Grant
- 2004-06-18 SI SI200432255T patent/SI2441767T1/sl unknown
- 2004-06-18 MX MX2013010748A patent/MX361003B/es unknown
- 2004-06-18 ES ES11163737.7T patent/ES2546415T3/es not_active Expired - Lifetime
- 2004-06-18 DK DK11163737.7T patent/DK2441767T3/en active
- 2004-06-18 PT PT111637377T patent/PT2441767E/pt unknown
-
2015
- 2015-07-30 IL IL240236A patent/IL240236B/en active IP Right Grant
- 2015-08-25 CY CY20151100744T patent/CY1116724T1/el unknown
Also Published As
Publication number | Publication date |
---|---|
SI2441767T1 (sl) | 2015-10-30 |
KR20120081637A (ko) | 2012-07-19 |
KR101315595B1 (ko) | 2013-10-08 |
IL240236A0 (en) | 2015-09-24 |
ES2546415T3 (es) | 2015-09-23 |
CY1116724T1 (el) | 2017-03-15 |
DK2441767T3 (en) | 2015-08-24 |
MX361003B (es) | 2018-11-23 |
IL240236B (en) | 2021-02-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP1638977A4 (en) | SALINOSPORAMIDES AND METHODS OF USE | |
ZA200603882B (en) | Substituted benzimidazole-, benztriazole-, and benzimidazolone-O-glucosides | |
IL175491A0 (en) | Substituted benzimidazole-, benztriazole-, and benzimidazolone-o-glucosides | |
HK1088837A1 (en) | Clk-peptide and slk-peptide | |
IL172704A0 (en) | Salinosporamides and methods for use thereof | |
GB0318546D0 (en) | Quinoxalinones and their use | |
GB0300804D0 (en) | Compounds and their use | |
GB0301143D0 (en) | Compounds and their use | |
HK1169120A1 (zh) | 孢菌酰胺及其使用方法 | |
PT2441767E (pt) | Salinosporamidas e seus métodos de utilização | |
GB0317133D0 (en) | Compounds and their use | |
GB0329079D0 (en) | Method and use | |
GB0311820D0 (en) | Compounds and their use | |
GB0302930D0 (en) | Compounds and their use | |
GB0316090D0 (en) | Compounds and their use | |
GB0314293D0 (en) | Compounds and their use | |
GB0314292D0 (en) | Compounds and their use | |
GB0314291D0 (en) | Compounds and their use | |
GB0311821D0 (en) | Compounds and their use | |
GB0316112D0 (en) | Compounds and their use | |
GB0310472D0 (en) | Compounds and their use | |
GB0310471D0 (en) | Compounds and their use | |
GB0310470D0 (en) | Compounds and their use | |
GB0316203D0 (en) | Compounds and their use | |
GB0309320D0 (en) | Compounds and their use |